Broomfield, CO, United States of America

Amir Genosar

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Galen Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amir Genosar. Retrieved from https://idiyas.com/inventor/amir-genosar-t5rhg9wx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amir Genosar: Inventor of a Tranexamic Acid Delivery Invention

Introduction

Amir Genosar is an inventor associated with Broomfield, Colorado, and Galen Limited. His patent work concerns concentrated tranexamic acid compositions designed for emergency treatment of severe bleeding.

Latest Patents

Genosar is named on 1 patent: “Concentrated Injectable Tranexamic Acid Compositions and Methods of Use Thereof.” The patent describes concentrated tranexamic acid compositions suitable for intramuscular administration using an auto-injector. It also covers methods for treating non-compressible hemorrhage, as well as kits and auto-injectors containing the compositions.

Career Highlights

The patent reflects work on a delivery approach intended to make tranexamic acid available through intramuscular injection, including in an auto-injector format. The disclosed methods focus on treating non-compressible hemorrhage.

Collaborations

Genosar’s listed coworkers include Xicheng Sun and Melissa Varner. His patent is associated with Galen Limited.

Conclusion

Amir Genosar’s patent contribution centers on concentrated injectable tranexamic acid and delivery methods intended for treating non-compressible hemorrhage.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…